Setanta AM tops pension returns
PENSION managed funds delivered positive returns during January, with an average return of 1.6pc for the month, according to Rubicon Investment Consulting.
Setanta Asset Management took top spot with a return of 2.5pc for the month, while Friends First/F&C propped up the league table with a return of 1.1pc. In the 12 months, the average return was 11.9pc.
Android boost for Sky customers
SKY TV customers will be able to control their TV from any Android smartphone or tablet.
The company has introduced remote control functionality to the Android version of the Sky+ app. People with an internet-connected Sky+HD box and an Android smartphone or tablet will be able to use their device to change channels as well as pause, play and rewind TV.
BP thanks refining for steady profits
FOURTH quarter profits from British oil company BP beat analysts' expectations yesterday thanks to a record performance from its refining division.
BP is the last of the big four western world oil companies to report quarterly earnings.
It said fourth quarter net profit, adjusted for non-operating items and accounting effects, fell to $3.984bn from $4.986bn a year earlier.
The company has sold $37.8bn worth of assets since the Macondo spill and taken a total charge against profits of $42.2bn – most of which has already been paid out.
Bruton defends enterprise plans
ENTERPRISE minister Richard Bruton defended his plan to integrate the County Enterprise Boards into local authorities, saying it was essential if the boards and local authorities were to deliver the "full gamut" of services to the small business sector.
Addressing the Oireachtas Committee on Jobs, Enterprise and Innovation, Mr Bruton acknowledged the plan had been criticised but said the move would allow both groups to offer more to businesses.
Allergen finds its money in migraine
Allergan, maker of the Botox anti-wrinkle treatment which has a large factory in Westport, Mayo, said its fourth quarter earnings rose, helped by sales of Botox for the recently approved use of treating migraine headaches.
The company said it earned $324m, or $1.06 per share, in the fourth quarter. That compared with $280m, or 90 cents per share, in the year-earlier period.
Excluding special items, Allergan said it earned $1.15 per share in the fourth quarter.